Drug Type T cell engagers (TCE) |
Synonyms 5T4-CD3 T cell engager (Sutro Biopharma) |
Target |
Mechanism 5T4 inhibitors(Trophoblast glycoprotein inhibitors), CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 29 Mar 2022 |